Risk Factors for 30-Day Hospital Readmission following Myeloablative Allogeneic Hematopoietic Cell Transplantation (allo-HCT)

Biology of Blood and Marrow Transplantation

Volumn 18, Issue 6, 2012, Pages 874-880

  Bejanyan, Nelli ^a   Bolwell, Brian J ^a   Lazaryan, Aleksandr ^a   Rybicki, Lisa ^b   Tench, Shawnda ^a   Duong, Hien ^a   Andresen, Steven ^a   Sobecks, Ronald ^a   Dean, Robert ^a   Pohlman, Brad ^a   Kalaycio, Matt ^a   Copelan, Edward A ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

30 Day readmission; Allo HCT; Allogeneic stem cell transplantation; Risk factors

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CHRONIC MYELOID LEUKEMIA; COMORBIDITY; DIARRHEA; FEMALE; FEVER; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEALTH CARE QUALITY; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELOABLATIVE STEM CELL TRANSPLANTATION; MYELODYSPLASTIC SYNDROME; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDER; OVERALL SURVIVAL; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PREDICTION; RELAPSE; RETROSPECTIVE STUDY; RISK FACTOR; THROMBOEMBOLISM; VOMITING; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGED; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LENGTH OF STAY; LEUKEMIA, LYMPHOID; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; PATIENT DISCHARGE; PATIENT READMISSION; QUALITY OF HEALTH CARE; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; WHOLE-BODY IRRADIATION;

EID: 84860837373     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2011.10.032     Document Type: Article

References (23)

1. Jencks S.F., Williams M.V., Coleman E.A. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med 2009, 360:1418-1428.
2. Ross J.S., Chen J., Lin Z., et al. Recent national trends in readmission rates after heart failure hospitalization. Circ Heart Fail 2010, 3:97-103.
3. Hernandez A.F., Greiner M.A., Fonarow G.C., et al. Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA 2010, 303:1716-1722.
4. Lindenauer P.K., Bernheim S.M., Grady J.N., et al. The performance of US hospitals as reflected in risk-standardized 30-day mortality and readmission rates for Medicare beneficiaries with pneumonia. J Hosp Med 2010, 5:E12-E18.
5. Gorodeski E.Z., Starling R.C., Blackstone E.H. Are all readmissions bad readmissions?. N Engl J Med 2010, 363:297-298.
6. Lindenauer P.K., Normand S.L., Drye E.E., et al. Development, validation, and results of a measure of 30-day readmission following hospitalization for pneumonia. J Hosp Med 2011, 6:142-150.
7. Keenan P.S., Normand S.L., Lin Z., et al. An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure. Circ Cardiovasc Qual Outcomes 2008, 1:29-37.
8. Mulvey G.K., Wang Y., Lin Z., et al. Mortality and readmission for patients with heart failure among U.S. News & World Report's top heart hospitals. Circ Cardiovasc Qual Outcomes 2009, 2:558-565.
9. Krumholz H.M., Merrill A.R., Schone E.M., et al. Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission. Circ Cardiovasc Qual Outcomes 2009, 2:407-413.
10. Silverstein M.D., Qin H., Mercer S.Q., Fong J., Haydar Z. Risk factors for 30-day hospital readmission in patients >/=65 years of age. Proc (Bayl Univ Med Cent) 2008, 21:363-372.
11. Hasan O., Meltzer D.O., Shaykevich S.A., et al. Hospital readmission in general medicine patients: a prediction model. J Gen Intern Med 2010, 25:211-219.
12. Kirby S.E., Dennis S.M., Jayasinghe U.W., Harris M.F. Patient related factors in frequent readmissions: the influence of condition, access to services and patient choice. BMC Health Serv Res 2010, 10:216.
13. Coleman E.A., Boult C. Improving the quality of transitional care for persons with complex care needs. J Am Geriatr Soc 2003, 51:556-557.
14. Coleman E.A., Berenson R.A. Lost in transition: challenges and opportunities for improving the quality of transitional care. Ann Intern Med 2004, 141:533-536.
15. Coleman E.A., Min S.J., Chomiak A., Kramer A.M. Posthospital care transitions: patterns, complications, and risk identification. Health Serv Res 2004, 39:1449-1465.
16. Ong M.K., Mangione C.M., Romano P.S., et al. Looking forward, looking back: assessing variations in hospital resource use and outcomes for elderly patients with heart failure. Circ Cardiovasc Qual Outcomes 2009, 2:548-557.
17. Grant M., Cooke L., Bhatia S., Forman S. Discharge and unscheduled readmissions of adult patients undergoing hematopoietic stem cell transplantation: implications for developing nursing interventions. Oncol Nurs Forum 2005, 32:E1-E8.
18. Atkinson K., Farewell V., Storb R., et al. Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease. Blood 1982, 60:714-720.
19. Linch D.C., Knott L.J., Thomas R.M., et al. T cell regeneration after allogeneic and autologous bone marrow transplantation. Br J Haematol 1983, 53:451-458.
20. Atkinson K. Reconstruction of the haemopoietic and immune systems after marrow transplantation. Bone Marrow Transplant 1990, 5:209-226.
21. Storek J., Dawson M.A., Storer B., et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 2001, 97:3380-3389.
22. Ochs L., Shu X.O., Miller J., et al. Late infections after allogeneic bone marrow transplantations: comparison of incidence in related and unrelated donor transplant recipients. Blood 1995, 86:3979-3986.
23. Shi-Xia X., Xian-Hua T., Hai-Qin X., Bo F., Xiang-Feng T. Total body irradiation plus cyclophosphamide versus busulphan with cyclophosphamide as conditioning regimen for patients with leukemia undergoing allogeneic stem cell transplantation: a meta-analysis. Leuk Lymphoma 2010, 51:50-60.